Robinson B H, MacKay N, Petrova-Benedict R, Ozalp I, Coskun T, Stacpoole P W
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
J Clin Invest. 1990 Jun;85(6):1821-4. doi: 10.1172/JCI114641.
Three patients with chronic lacticacidemia and deficiency of the pyruvate dehydrogenase complex demonstrated in cultured skin fibroblasts showed abnormalities on Western blotting with anti-pyruvate dehydrogenase complex antiserum which were not located in the E1 (alpha and beta) component of the complex. One of these patients had an enzymatically demonstrable deficiency in the E2 dihydrolipoyl transacetylase segment of the complex and very low observable E2 protein component on Western blotting of fibroblast proteins. The other two patients had abnormalities observable in the X component but no observable reduction in either E1, E2, or E3 enzymatic activities. One patient appeared to have a missing X component while the other had two distinct bands where X should be on Western blotting of fibroblast proteins. All three patients appeared to have severe clinical sequelae resulting from these defects. This is the first time that defects in either the E2 or the X component of the pyruvate dehydrogenase complex have been observed in the human population.
在培养的皮肤成纤维细胞中表现出慢性乳酸血症和丙酮酸脱氢酶复合体缺乏的三名患者,在用抗丙酮酸脱氢酶复合体抗血清进行蛋白质免疫印迹分析时显示出异常,这些异常并不位于该复合体的E1(α和β)组分中。其中一名患者在该复合体的E2二氢硫辛酰胺转乙酰酶片段存在酶学上可证实的缺乏,并且在成纤维细胞蛋白质的蛋白质免疫印迹分析中可观察到的E2蛋白组分非常低。另外两名患者在X组分中可观察到异常,但E1、E2或E3酶活性均未观察到降低。一名患者似乎缺失X组分,而另一名患者在成纤维细胞蛋白质的蛋白质免疫印迹分析中,在X应出现的位置有两条不同的条带。所有三名患者似乎都因这些缺陷而出现了严重的临床后遗症。这是首次在人类群体中观察到丙酮酸脱氢酶复合体的E2或X组分存在缺陷。